Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The HIV Virologic Outcomes of Different Interventions Among Treatment-Experienced Patients With 2 Consecutive Detectable Low-Level Viremia.

Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) - 1 Jan 2000

Pham Tri, Alrabaa Sally, Somboonwit Charurut, Le Hung, Montero Jose

Abstract excerpt

BACKGROUND: Approaches to treatment-experienced HIV-infected patients with persistent low-level viremia are limited by current commercial resistance genotyping assays when the viral load (VL) is <500 copies/mL. The best intervention to achieve virologic suppression in this population is unclear. METHODS: This is a case control retrospective chart review study of 149 HIV-infected patients with a VL of 50 to 1000...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genotype
Share to HIV-1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Infections

Share to Viral Load

Share to Viremia

Source

Identifiers

PMID: 21368016
DOI: 10.1177/1545109710385122

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The HIV Virologic Outcomes of Different Interventions Among Treatment-Experienced Patients With 2 Consecutive Detectable Low-Level Viremia.PMID 21368016Read ↗

Antiretroviral drug resistance in HIV-1-infected patients experiencing persistent low-level viremia during first-line therapy.Semantic proximity Read ↗

Improved viral suppression after treatment optimization in HIV-infected patients with persistent low-level viremia.Semantic proximity Read ↗

Significance and clinical management of persistent low-level viremia and very-low-level viremia in HIV-1-infected patients.Semantic proximity Read ↗

HIV: how to manage low-level viraemia in people living with HIVSemantic proximity Read ↗

How relevant is the HIV low level viremia and how is its management changing in the era of modern ART? A large cohort analysis.Semantic proximity Read ↗

Prevalence and Significance of HIV-1 Drug Resistance Mutations among Patients on Antiretroviral Therapy with Detectable Low-Level ViremiaSemantic proximity Read ↗

Reliability and Clinical Relevance of the HIV-1 Drug Resistance Test in Patients With Low Viremia LevelsSemantic proximity Read ↗

Genotypic resistance in HIV-1-infected patients with persistently detectable low-level viremia while receiving highly active antiretroviral therapy.Semantic proximity Read ↗

Drug resistance at low viraemia in HIV-1-infected patients with antiretroviral combination therapy.Semantic proximity Read ↗

Performance of HIV-1 drug resistance testing at low-level viremia and its ability to predict future virologic outcomes and viral evolution in treatment-naive individuals.Semantic proximity Read ↗

Net benefits of resistance testing directed therapy compared with standard of care in HIV-infected patients with virological failure: A meta-analysis.Semantic proximity Read ↗

Limited benefit of antiretroviral resistance testing in treatment-experienced patients: a meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.